DTaP/IPV/Hib+HepB vaccine (2025)
Details
- Supplier(s)
- GLAXOSMITHKLINE UK LIMITED
- Value
- £1
- Duration
- 4 years
- Topic
- Vaccines
- Published
- 25 July 2024
- Source
- uk:contracts_finder
Tender description
A contract for the supply of DTaP/IPV/Hib+HepB vaccine, to be used as part of the national childhood immunisation programme. Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months. Value - The value has been withheld so as not to prejudice the legitimate commercial interest of the supplier.
Timeline
- Completed: Award published25 July 2024Current notice
- Completed: Award date1 April 2025
- Next: Contract expiry date31 March 2029in 2 years
About the buyer
UK Health Security Agency is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33651600 · Vaccines
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov |
2 similar open tenders
See more open tenders related to DTaP/IPV/Hib+HepB vaccine (2025).
- Open tender
Contract Notice
- Open tender
Under-18 SARS-CoV-2 Vaccine Supply (2026)
Related buyers
Buyers similar to UK Health Security Agency.
- 2,351£1.6bn
- 814£4.8bn
- 592£8.7bn
- 391£3.7bn
- 302£18.9m
- 263£361.8m
- 227£228.9m
- 219£424.8m
- 217£10.1bn
- 148£44.6m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
